Enantioselective BINOL-Phosphoric Acid
Catalyzed Pictet-Spengler Reactions of
Nishant V. Sewgobind, Martin J. Wanner, Steen Ingemann, FIGURE 1. Tetrahydro- -carbolines obtained via organocatalytic
Rene´ de Gelder,† Jan H. van Maarseveen, and asymmetric Pictet-Spengler reactions.
Pictet-Spengler Reaction
Van’t Hoff Institute for Molecular Sciences, UniVersity of Amsterdam, Nieuwe Achtergracht 129, 1018 WS, Amsterdam, Various stereoselective Pictet-Spengler reactions have been described of which especially Cook’s approach using tryptophan
esters as chiral precursors is noteworthy.4b However, the ester
functionality had to be removed in a multistep sequence.
Recently, an organocatalytic approach toward enantioenriched
tetrahydro- -carbolines (e.g., 2 in Figure 1) was developed
mediated by a chiral thiourea catalyst (5-10 mol % catalyst,
Optically active tetrahydro- -carbolines were synthesized via 65-81% yield, and 85-93% ee).5 This reaction appeared to an (R)-BINOL-phosphoric acid-catalyzed asymmetric Pictet- be limited to aliphatic aldehydes and, in addition, N-acetyl group Spengler reaction of N-benzyltryptamine with a series of aromatic and aliphatic aldehydes. The tetrahydro- -carbolines List and co-workers developed an asymmetric Pictet-Spengler were obtained in yields ranging from 77% to 97% and with cyclization of an iminium diester that provided tetrahydro- - ee values up to 87%. The triphenylsilyl-substituted BINOL- carbolines 3 in 40-96% yield and 62-96% ee with triisopro-
phosphoric acid proved to be the catalyst of choice for the pylphenyl-substituted (S)-BINOL phosphoric acid (20 mol %) reaction with aromatic aldehydes. For the aliphatic aldehydes, as the catalyst.6 Although both aromatic and aliphatic aldehydes 3,5-bistrifluoromethylphenyl-substituted BINOL-phosphoric were accepted in this reaction, the method required the presence acid was identified as the best catalyst.
of two ester functionalities and is therefore of limited utility.
Within our research program on the development of asym- metric reactions of iminium ions catalyzed by chiral Brønsted Compounds containing the tetrahydro- -carboline core (1)
acids,7 we recently reported a catalytic asymmetric Pictet- are of great interest because of their inherent biological Spengler reaction via an N-sulfenyliminium ion catalyzed by a activity.1–3 Tetrahydro- -carbolines are generally obtained via bis-trifluoromethylphenyl-substituted (R)-BINOL phosphoric the Pictet-Spengler reaction of tryptamine with a variety of acid (5-10 mol %). Both alkyl- and aryl-substituted tetrahydro- aromatic and aliphatic aldehydes in the presence of a Brønsted -carbolines 4 were obtained in 77-90% yield in two steps
(cyclization and removal of the tritylsulfenyl group in a one-pot procedure) with ee values up to 87%.8 † X-Ray crystal structure determination: Institute for Molecules and Materials, Radboud University, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
(4) (a) Pictet, A.; Spengler, T. Ber. Dtsch. Chem. Ges. 1911, 44, 2030–2036.
(1) For their use as anti-viral agents, see: (a) Gudmundsson, K. WO (b) Cox, E. D.; Cook, J. M. Chem. ReV. 1995, 95, 1797–1842.
2007002051, 2007. (b) Gudmundsson, K.; Miller, J. F.; Sherrill, R. G.; Turner, (5) Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 10558–
E. M. WO 2006015035, 2006. For the application in the development of
anticancer agents, see:(c) Shen, Y.-C.; Chen, C.-Y.; Hsieh, P.-W.; Duh, C.-Y.; (6) Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 128, 1086–
Lin, Y.-M.; Ko, C.-L. Chem. Pharm. Bull. 2005, 53, 32–36. For their application
in the treatment of male erectile dysfunction, see: (d) Sui, Z.; Guan, J.; Macielag, (7) For recent reviews on catalysis by chiral Brønsted acids, see: (a) Connon, M. J.; Jiang, W.; Qiu, Y.; Kraft, P.; Bhattacharjee, S.; John, T. M.; Craig, E.; S. J. Angew. Chem., Int. Ed. 2006, 45, 3909–3912. (b) Akiyama, T.; Itoh, J.;
Haynes-Johnson, D.; Clancy, J. Bioorg. Med. Chem. Lett. 2003, 13, 761–765.
Fuchibe, K. AdV. Synth. Catal. 2006, 348, 999–1010. (c) Taylor, M. S.; Jacobsen,
(2) (a) Kawasaki, T.; Higuchi, K. Nat. Prod. Rep. 2005, 22, 761–793. (b) Yu,
E. N. Angew. Chem., Int. Ed. 2006, 45, 1520–1543. (d) Akiyama, T. Chem.
J.; Wang, T.; Liu, X.; Deschamps, J.; Anderson, J. F.; Liao, X.; Cook, J. M. J. Org. ReV. 2007, 107, 5744–5758. (e) Connon, S. J. Org. Biomol. Chem. 2007, 5,
Chem. 2003, 68, 7565–7581. (c) Liao, X.; Zhou, H.; Yu, J.; Cook, J. M. J. Org.
3407–3417. For a convenient protocol for the synthesis of these chiral phosphoric Chem. 2006, 71, 8884–8890. (d) Ma, J.; Yin, W.; Zhou, H.; Cook, J. M. Org. Lett.
acids, see: (f) Bartoszek, M.; Beller, M.; Deutsch, J.; Klawonn, M.; Ko¨ckritz, 2007, 9, 3491–3494.
A.; Nemati, N.; Pews-Davtyan, A. Tetrahedron 2008, 64, 1316–1322.
(3) (a) Herraiz, T. J. Chromatogr. A 2000, 881, 483–499. (b) Herraiz, T.;
(8) Wanner, M. J.; van der Haas, R. N. S.; de Cuba, K.; van Maarseveen, Galisteo, J.; Chamorro, C. J. Agric. Food Chem. 2003, 51, 2168–2173.
J. H.; Hiemstra, H. Angew. Chem., Int. Ed. 2007, 46, 7485–7487.
10.1021/jo8010478 CCC: $40.75  2008 American Chemical Society J. Org. Chem. 2008, 73, 6405–6408
Winterfeldt Oxidation and Known
Pyrroloquinolone Derivatives
N-Substituted tetrahydro- -carbolines are the starting materi- FIGURE 2. Chiral phosphoric acids.
als of choice for the pharmaceutically relevant pyrroloquinolones Catalyst Screeninga
5 via the Winterfeldt oxidation.9
Pyrroloquinolones (e.g., 6 in Scheme 2) are selective phos-
phodiesterase 5 (PDE5) inhibitors,10 and the related quinolac-
tacins such as 7 are known to play a key role in apoptosis.11,12
Pyrroloquinolone 610h was proven to be superior in selectivity
and potency in the treatment of male erectile dysfunction
compared to the nowadays commercially available Viagra
(sildenafil),13 Levitra (vardenafil),14 and Cialis (tadalafil).15
Pyrroloquinolones such as 6 have been synthesized via an
asymmetric Pictet-Spengler reaction from tryptamine func- tionalized with 1-naphthalen-1-yl-ethylamine as the chiral auxiliary.10a Starting from tryptophan a diastereoselective Pictet-Spengler reaction was achieved and the ester group was removed in 4 steps.10h Another route starts with (one pot) consecutive imine formation from tryptamine in boiling toluene, followed by an acid-catalyzed Pictet-Spengler cyclization and resolution with a chiral acid to afford the tetrahydro- -carboline intermediate with high optical purity. After installing the N-benzyl the stage was set for the Winterfeldt oxidation.10e,g Reaction was conducted with 8 (0.05 mmol), 12 (3 equiv), and
powdered 4 Å MS (75 mg) in toluene (0.5 mL) with 2 mol % catalyst Because N-benzyl-protected tetrahydro- -carbolines are the at 70 °C for 24 h. b Determined by 1H NMR spectroscopy. c Determined most commonly used substrates for the Winterfeldt oxidation by HPLC on a chiral column (Chiralcel OD).
we herein report an asymmetric organocatalytic Pictet-Spenglerreaction directly starting from N-benzyltryptamine.
As 2,3-dihydrobenzofuran-5-carboxaldehyde 12 is employed
in the synthesis of PDE5 inhibitors,10 we have chosen this (9) (a) Winterfeldt, E. Liebigs Ann. Chem. 1971, 745, 23–30. (b) Warneke,
J.; Winterfeldt, E. Chem. Ber. 1972, 105, 2120–2125. (c) Boch, M.; Korth, T.;
particular aldehyde to study the enantioselective Pictet-Spengler Nelke, J. M.; Pike, D.; Radunz, H.; Winterfeldt, E. Chem. Ber. 1972, 105, 2126–
reaction starting from N-benzyltryptamine 8 providing tetrahy-
dro- -carboline 13. A series of enantiopure phosphoric acid
(10) (a) Jiang, W.; Sui, Z.; Chen, X. Tetrahedron Lett. 2002, 43, 8941–8945.
(b) Jiang, W.; Sui, Z.; Chen, X. Org. Lett. 2003, 5, 43–46. (c) Jiang, W.; Sui,
catalysts were screened (see Figure 2) and the results are listed Z.; Macielag, M. J.; Walsh, S. P.; Fiordeliso, J. J.; Lanter, J. C.; Guan, J.; Qiu, Y.; Kraft, P.; Bhattacharjee, S.; Craig, E.; Haynes-Johnson, D.; John, T. M.;
Clancy, J. J. Med. Chem. 2003, 46, 441–444. (d) Lanter, J. C.; Sui, Z.; Macielag,
Low ee values were obtained with the binol phosphoric acids M. J.; Fiordeliso, J. J.; Jiang, W.; Qiu, Y.; Bhattacharjee, S.; Kraft, P.; John, 9a-f, except when triphenylsilyl catalyst 9c was used (Table
T. M.; Haynes-Johnson, D.; Craig, E.; Clancy, J. J. Med. Chem. 2004, 47, 656–
1, entry 3). The H8-BINOL phosphoric acids 10a and 10b gave
662. (e) Li, X.; Branum, S.; Russell, R. K.; Jiang, W.; Sui, Z. Org. Process Res.
V. 2005, 9, 640–645. (f) Jiang, W.; Guan, J.; Macielag, M. J.; Zhang, S.; Qiu,
almost full conversions and similar ee values as the related Y.; Kraft, P.; Bhattacharjee, S.; John, T.M. ; Haynes-Johnson, D.; Lundeen, S.; BINOL phosphoric acids. VAPOL hydrogen phosphate 11
Sui, Z. J. Med. Chem. 2005, 48, 2126–2133. (g) Willemsens, B.; Vervest, I.;
proved to be unsuitable for this reaction as only low conversion Ormerod, D.; Aelterman, W.; Fannes, C.; Mertens, N.; Marko´, I. E.; Lemaire,
S. Org. Process Res. DeV. 2006, 10, 1275–1281. (h) Lemaire, S.; Willemsens,
and enantioselectivity were obtained.
B.; Marko´, I. E. Synlett 2007, 5, 709–712.
With catalyst 9c giving the best result, we then investigated
(11) Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J. H. Org. Biomol. Chem 2006, 4, 1512–1519, and references cited therein.
the influence of catalyst loading and reaction temperature for (12) Zhang, X.; Jiang, W.; Sui, Z. J. Org. Chem. 2003, 68, 4523–4526.
this catalyst. In the absence of catalyst, it appeared that 13 was
(13) Brook, G. Drugs Today 2000, 26, 125–134.
formed as a racemic mixture in a yield of 23-35% after 24 h (14) Sorbera, L. A.; Martin, L.; Rabasseda, X.; Castaner, J. Drugs Future 2001, 26, 141–144.
(as observed in three different experiments).16 Increasing the (15) (a) Sorbera, L. A.; Martin, L.; Leeson, P. A.; Castaner, J. Drugs Future amount of catalyst to 5 mol % gave full conversion after 13 h 2001, 26, 15–19. For the discovery of tadalafil, see: (b) Daugan, A.; Grondin,
P.; Ruault, C.; Gouville, A.-C. L. M.; Coste, H.; Kirilovsky, J.; Hyafil, F.;
Labaudinie`re, R. J. Med. Chem. 2003, 46, 4525–4532. (c) Daugan, A.; Grondin,
(16) See for an uncatalyzed Pictet-Spengler reaction with N-benzyltryptamine P.; Ruault, C.; Gouville, A.-C. L. M.; Coste, H.; Kirilovsky, J.; Linget, J.-M.; see: Soerens, D.; Sandrin, J.; Ungemach, F.; Mokry, P.; Wu, G. S.; Yamanaka, Hyafil, F.; Labaudinie`re, R. J. Med. Chem. 2003, 46, 4533–4542.
E.; Hutchins, L.; DiPierro, M.; Cook, J. M. J. Org. Chem. 1979, 44, 535–545.
J. Org. Chem. Vol. 73, No. 16, 2008 Solvent and Additive Screeninga
Scope of the Reactiona
a Reaction was conducted with 8 (0.05 mmol), 12 (3 equiv), and
drying agent (75 mg) in 0.5 mL of solvent with 2 mol % 9c at 70 °C
for 24 h. b Reaction monitored by TLC. c Determined by HPLC on a chiral column (Chiralcel OD). d Stirred for 48 h.
a Reaction was conducted with 8 (0.2 mmol), aldehyde (3 equiv), and
and 13 was obtained with an ee of 85%. With 10 mol % catalyst
powdered 4 Å MS (300 mg) in 2 mL of toluene with 2 mol % of 9c at
the reaction was complete in 4 h and afforded 13 with essentially
70 °C for 24 h unless otherwise stated. b Isolated yield. c Determined by
HPLC on a chiral column. d With Chiralcel OD. e 5 mol % of 9c was
the same ee (86%) as obtained with a catalyst loading of 2 or used. f With Chiralpak AD. g With Chiralcel OD-H. h A different 5 mol % (see also Table 1). The best results in terms of ee workup procedure was performed to prevent racemization, see the were obtained at a temperature of 70 °C; at 50 °C the reaction Supporting Information. i Reaction performed with catalyst 9a (2 mol
of 8 with 12 was complete in 48 h (81% ee) and at 90 °C full
conversion was observed after 12 h (82% ee) with a catalystloading of 2 mol %.
The study of the effects of solvent and additives is sum- marized in Table 2. The reaction proceeded at best in aromaticsolvents with a clear preference for toluene. In the absence ofmol sieves, the reaction was incomplete after 24 h and theproduct was obtained with a modest ee only (41%). Acomparable result was obtained by using sodium sulfate as thedrying agent. Slightly lower ee values were obtained when 3 Å FIGURE 3. X-ray crystal structure of 14a.
and 5 Å MS were employed as compared to 4 Å MS. Possibly,water is able to break up the tight complex between the BINOL- gave the lowest ee and with the easy enolizable phenylacetal- phosphate and the cyclization precursor.
dehyde no product could be obtained (entry 15).
In our final optimization experiments, the stability of the The Pictet-Spengler reactions with 2,3-dihydrobenzofuran- Pictet-Spengler product was examined. We exposed enan- 5-carboxaldehyde 12 and p-bromobenzaldehyde were also
tiopure (S)-13 to the reaction conditions (2 mol % of 9c, 2 equiv
performed on a 1 mmol scale giving 13 and 14a in similar yields
of 13, 4 Å MS, toluene, 70 °C, 24 h) and no racemization was
and ee values. Both products were readily recrystallized to observed. By application of the same reaction conditions to the enantiomeric purity. From 14a an X-ray crystallographic
racemic product 13 no enantiomeric enrichment was observed
structure (Figure 3) was obtained revealing the absolute con- thus suggesting that the BINOL-phosphoric acid catalyzed figuration which was found to be (S). This is in analogy with Pictet-Spengler reaction of N-benzyltryptamine with 12 is
irreversible under our reaction conditions.
our previous results obtained for the Pictet-Spengler reactionwith N-tritylsulfenyltryptamine.8 The required biologically active With the optimal reaction conditions identified, we investi- (R)-enantiomer of benzofuran 13 was prepared with comparable
gated the reaction with a series of aliphatic and aromaticaldehydes. The results are presented in Table 3.
yield and ee by using the corresponding (S)-triphenylsilyl-
substituted BINOL catalyst 9c.
All reactions proceeded smoothly to give the corresponding products 13 and 14 in good to high yields (77-97%). Both
In conclusion, we have developed an organocatalyzed asym- aromatic (bearing electron donating and electron withdrawing metric Pictet-Spengler reaction of N-benzyltryptamine (8) with
groups) and aliphatic aldehydes are tolerated. Moderate to good a variety of aldehydes. Both aromatic and aliphatic aldehydes ee values were obtained in the range of 61-87%, with the best can be used in this reaction catalyzed by an enantiopure BINOL- result with p-nitrobenzaldehyde (Table 3, entry 2). Remarkably, derived phosphoric acid. The corresponding adducts are obtained low ee values (0-20%) were obtained with m-chlorobenzalde- in good to high yields and moderate to good ee values in one hyde and with 3,5-bis(trifluoromethyl)benz-aldehyde (entries 4 step. In addition, our scaleable method shortens the synthesis and 5). The reason for the low ee in these two cases is unclear.
toward the pharmaceutically very relevant PDE5 inhibitors of Of the aliphatic aldehydes tested, 3-phenylpropanal (entry 16) the pyrroloquinolone class by three steps.
J. Org. Chem. Vol. 73, No. 16, 2008 Experimental Section
108.8, 71.3, 64.1, 58.1, 48.4, 29.6, 21.2; IR (film) ν 3407, 3027,2896, 2842, 2794, 1613, 1489; HRMS (FAB) m/z calcd for [M + (S)-2-Benzyl-1-dihydrobenzofuryl-1,2,3,4-tetrahydro- -carbo-
H]+ C26H25N2O 381.1967, found 381.1972.
line (13). A mixture of N-benzyltryptamine (8, 250 mg, 1 mmol),
(S)-2-Benzyl-1-(p-bromophenyl)-1,2,3,4-tetrahydro- -carbo-
4 Å (powdered) molecular sieves (1.5 g), and catalyst 9c (17.3 mg,
line (14a). Compound 14a was obtained in a yield of 92% (384.7
0.02 mmol) in 10 mL of toluene was stirred for 5 min at room mg, 87% ee) following the procedure described for 13 with
temperature. Subsequently, 2,3-dihydrobenzofuran-5-carboxalde- p-bromobenzaldehyde (222.0 mg, 1.2 mmol). Crystals were formed hyde (12, 178 mg, 1.2 mmol) was added and the mixture was stirred
as described for (S)-13 to give 41.2 mg (10% yield, 10% ee) of
at 70 °C for 24 h under a nitrogen atmosphere. The reaction mixture solid. The filtrate was concentrated to a small volume and diluted was then cooled to room temperature and 3 g of silica gel was with PE (2 mL). After standing in the refrigerator for 18 h, 343.5 added followed by 5 mL of petroleum ether (PE). The resulting mg (82% yield, 98% ee) of solid was obtained. Recrystallization slurry was stirred for 5 min and filtered over a Celite path containing from EtOH gave enantiomerically pure (S)-14a (>99% ee deter-
2 g of silica gel (glass filter) and rinsed with 90 mL of eluent (PE: mined on a Chiralcel OD column of heptane:isopropanol ) 97:3, EtOAc ) 5:1). Concentration of the filtrate afforded tetrahydro- 1 mL/min, tr major ) 12.3 min, tr minor ) 16.4 min) which was -carboline 13 in a yield of 69% (262.3 mg, 84% ee).
used for X-ray crystal structure analysis. Mp 171-172.5 °C; [R]22D To obtain crystals the solid was dissolved in 0.5 mL of hot EtOAc +67.4 (c 0.23, CHCl3); 1H NMR (400 MHz; CDCl3) δ 7.56-7.50 and diluted with 1 to 2 mL of PE. The resulting solution was kept (m, 3H), 7.36-7.31 (m, 6H), 7.30-7.24 (m, 2H), 7.24-7.21 (m, for 18 h in the refrigerator to give 35.3 mg (9% yield) of racemic 1H), 7.18-7.11 (m, 2H), 4.65 (s, 1H), 3.89 (d, J ) 13.6 Hz, 1H), crystals. The filtrate was concentrated to a small volume and diluted 3.42 (d, J ) 13.6 Hz, 1H), 3.26-3.21 (m, 1H), 2.96-2.88 (m, with PE (2 mL). After standing in the refrigerator for 18 h, 227 1H), 2.85-2.80 (m, 1H), 2.73-2.67 (m, 1H); 13C NMR (75.5 MHz; mg (60% yield, 96% ee) of solid was obtained. Recrystallization CDCl3) δ 140.7, 139.3, 136.4, 134.1, 131.9, 130.7, 128.7, 128.4, from EtOH gave enantiomerically pure (S)-13 (99% ee determined
127.2, 127.1, 122.0, 121.8, 119.5, 118.4, 110.9, 109.3, 63.7, 58.3, by chiral HPLC on a Chiralcel OD column of heptane:isopropanol 48.1, 21.1; IR (NaCl) ν 3406, 2796, 1483; HRMS (FAB) m/z calcd.
) 98:2, 0.8 mL/min, tr major ) 21.0 min, tr minor ) 24.3 min).
for [M + H]+ C24H22N2Br 417.0966, found 417.0954.
70 (c 0.25, CHCl3); 1H NMR (400 MHz; Supporting Information Available:
3) δ 7.57-7.55 (m, 1H), 7.43-7.34 (m, 5H), 7.31-7.28 (m, 2H), 7.24-7.18 (m, 2H), 7.16-7.11 (m, 2H), 6.80 (d, J ) 8.1 Hz, data, copies of 1H and 13C NMR spectra, and chromatograms 1H), 4.62-4.58 (m, 3H), 3.98 (d, J ) 13.6 Hz, 1H), 3.40 (d, J ) of the compounds in Table 3, as well as of the catalysts 10a
13.6 Hz, 1H), 3.30-3.24 (m, 1H), 3.23-3.13 (m, 2H), 2.99-2.92 and 10b, and detailed experimental procedures. This material
(m, 1H), 2.85-2.80 (m, 1H), 2.73-2.68 (m, 1H); 13C NMR (75.5 is available free of charge via the Internet at
MHz; CDCl3) δ 160.0, 139.5, 136.2, 135.3, 133.2, 128.9, 128.7,128.2, 127.7, 127.2, 126.8, 125.4, 121.4, 119.3, 118.2, 110.7, 108.9, J. Org. Chem. Vol. 73, No. 16, 2008



<Back Having trouble viewing this email? Click here November 2010 Dear Practitioners, Sports medicine is a hot topic all over the world. I wish to share with you some preliminary results from our pilot study being conducted by Dr. Maryanne Cowan at her practice in New Jersey. Dr. Cowan has an elite clientele of professional athletes who are experiencing significant improvemen

- visualisation des candidatures -

- Visualisation des Candidatures - Mandat de recherche pour chercheur 1. Inf ormations relatives au demandeur de subvention 1.1. Identité du demandeur Titre / Fonction / Statut aux Cliniques Saint-Luc Résidente (chef de clinique adjoint dès le 01/01/2014) 1.2. Veuillez remplir le curriculum vitae et joindre une photo format carte d'identité A. Données identité ch de la

© 2010-2017 Pdf Pills Composition